drugset / Trial / NCT01679002
Steady-state Pharmacokinetics of BIA 2-093 and Oxcarbazepine in Healthy Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
To investigate the steady-state pharmacokinetics of once-daily and twice-daily regimens of BIA 2-093 and twice-daily regimen of Oxcarbazepine (Trileptal®) in healthy subjects and to assess the tolerability of such regimens in healthy subjects.
Timeline
- Start
- 2003-10
- Primary completion
- 2003-12
- Completion
- 2003-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eslicarbazepine acetate | Unknown | 450 mg | Oral |
| Subject | Eslicarbazepine acetate | Unknown | 900 mg | Oral |
| Subject | Oxcarbazepine | Small molecule | 450 mg | Oral |